Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TESAR: Surgery vs Chemoradiotherapy for Early Rectal Cancer
NCT02371304Phase 3Unknown
- Sponsor
- Amsterdam University Medical Center
- Start
- Oct 2015
- Primary completion
- Jun 2022
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of capecitabine in rectal cancer, sponsored by Amsterdam University Medical Center. Status: unknown.
02
Drugs
capecitabine
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02371304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02371304.